Jul 30, 2020 - Health

The deep decline in vaccine sales

GSK's Twinrix vaccine. Photo: Sven Hoppe/picture alliance via Getty Images

Global stay-at-home orders stemming from the coronavirus pandemic — especially those in the U.S. — have led to steep sales declines in routine vaccinations.

The big picture: Although more people are getting their vaccines now, "there remains some way to go to get back to pre-COVID levels for adult vaccinations," GlaxoSmithKline CEO Emma Walmsley said on an investor call Wednesday.

By the numbers:

Sales of GlaxoSmithKline's vaccines in the second quarter plummeted 29% from the same period in 2019, totaling £1.13 billion.
Pfizer's vaccine sales fell 9% to $1.25 billion. The drop was especially severe in the U.S. for Pfizer's main vaccine, Prevnar 13, due to the "unfavorable impact of disruptions to wellness visits," the company said.
Sanofi said its vaccine sales slumped 7% to €927 million because of the "global confinements."
Merck will report its second-quarter results on Friday. Wall Street expects Merck's vaccine sales dropped 26% year over year.

Yes, but: The major vaccine manufacturers said uptake was rising a lot in Europe and developing countries.

But global sales dragged because of the shutdowns in the U.S., where drug companies charge the highest prices in the world.

Go deeper: The pandemic has put a lot of children behind the curve on routine vaccinations

Go deeper

Orion Rummler

16 hours ago - Politics & Policy

House Democrats to investigate scientist leading "Operation Warp Speed"

House Majority Whip James Clyburn (D-SC) on July 31. Photo: Erin Scott/Pool/AFP via Getty Images

House Democrats on the committee charged with overseeing the federal government's response to the coronavirus announced an investigation Thursday into "Operation Warp Speed," the Trump administration's efforts to accelerate the development and distribution of a vaccine.

Why it matters: In an effort to quickly distribute a vaccine, the Trump administration has bought initial batches from a handful of pharmaceutical companies before knowing whether they are safe and effective, Axios' Bob Herman reports.

Go deeper (1 min. read)

Eileen Drage O'Reilly

15 hours ago - Health

Fauci's guidance on pre-vaccine coronavirus treatments

Illustration: Aïda Amer/Axios

Antibody drugs and various medicine cocktails against the coronavirus are progressing and may provide some relief before vaccines.

The big picture: Everyone wants to know how and when they can return to "normal" life, as vaccines are not expected to be ready for most Americans for at least a year. Two therapies are known to be helpful, and more could be announced by late September, NIAID Director Anthony Fauci tells Axios.

Go deeper (3 min. read)

Kim Hart

Aug 13, 2020 - Economy & Business

The pandemic is hitting city budgets harder than the Great Recession

Data: National League of Cities; Chart: Axios Visuals

With tax revenue in free-fall and expenditures dramatically rising, the coronavirus pandemic is on pace to hit cities' finances even harder than the Great Recession.

Why it matters: Almost all cities are required to balance their budgets, and at this rate they'll have no choice but to cut more services, layoff or furlough more workers and freeze capital projects.